SCHEMBL9023717

SCHEMBL9023717

Nc1ccc2c(CNCCN3CCOCC3)nn3c4ccccc4c(=O)c1c23

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ PARP1 P09874 3/20 0.41
▸ KDM4E B2RXH2 7/20 0.40
▸ ALDH1A1 P00352 6/20 0.40
▸ HSD17B10 Q99714 5/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ HPGD P15428 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ NPY1R P25929 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ ALOX15 P16050 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAD52 P43351 1/20 0.39
▸ SMARCA2 P51531 1/20 0.38
▸ ABCB1 P08183 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9023944 0.88 KDM4E (0.46) L3MBTL1PARP1KDM4EALDH1A1HSD17B10
SCHEMBL9025023 0.86 L3MBTL1 (0.50) L3MBTL1PARP1KDM4EALDH1A1HSD17B10
SCHEMBL9024575 0.83 NQO2 (0.36) HPGD
SCHEMBL9024667 0.81 NQO1 (0.39) KDM4EALDH1A1KMT2AMEN1LMNA
SCHEMBL9739130 0.80 NQO2 (0.46) PARP1KDM4EALDH1A1HSD17B10HPGD
SCHEMBL9024406 0.76 KMT2A (0.39) L3MBTL1PARP1KDM4EALDH1A1HSD17B10
SCHEMBL9023847 0.72 G6PD (0.39) HPGDHTTMAPT
SCHEMBL9024703 0.71 NQO2 (0.48) —
SCHEMBL9024299 0.70 NQO2 (0.49) —
SCHEMBL9023722 0.70 TOP2A (0.38) L3MBTL1PARP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0347749-B1 Pyrazoloacridone derivatives with anti-tumoral activity KYOWA HAKKO KOGYO KK (JP) 1996-04-24 — — EP disclosed
Send feedback